EFFECTS AND SAFETY NOTES
Retatrutide effects differ in studies and personal stories.
Phase 2 doctors watched the study groups. No clinic checked stories told by people using research bottles.
Retatrutide study findings carry more weight than stories
Retatrutide isn't approved or prescribed. Two kinds of reports circulate. You need to know which kind you are reading.
First are the Phase 2 studies, early tests in people. Doctors knew each dose and watched each person. One obesity study found a 24.2% weight change at 48 weeks. A liver study found an 82.4% liver-fat drop at 24 weeks.
People also tell stories after using bottles sold for research. No one can confirm the dose or contents. No clinic watched those people. Their stories tell what someone felt. They can't show that retatrutide caused the change.
Ask who watched the person and checked the bottle.
Phase 2 retatrutide studies found weight, liver, and sugar changes
Body weight. A 48-week Phase 2 obesity study followed 338 adults. With 12 mg, average weight fell 24.2%. The placebo group got a shot without retatrutide. Their weight fell 2.1% [1]. A 2025 review covered 26 studies. It found up to 22.1% loss with 12 mg at 48 weeks. Tirzepatide reached 17.8% with 15 mg after 72 weeks. Semaglutide reached 13.9% with 2.4 mg after 68 weeks [9]. The drugs weren't tested against each other.
Liver fat. Another Phase 2 study followed 98 people. They had both obesity and fatty liver disease. With 12 mg, liver fat fell 82.4% at 24 weeks. A scan measured the fat. Eighty-six percent reached the normal mark below 5% [5]. By 48 weeks, the drop was 86.0%. Another Phase 2 review allowed for the placebo result. It found an 81% change for retatrutide. Semaglutide had 41%, and tirzepatide had 47% [7]. Again, no study tested the drugs together.
Blood sugar. A Phase 2 diabetes study used a blood test covering several months. With 12 mg, that reading fell 2.02 points. Placebo brought a 0.01 point fall [2]. No one had a severe sugar drop. No one died. A 2026 review found drops up to 2.16% in blood sugar. Weight fell as much as 26.56% [12].
Your result could differ from every study average.
People report retatrutide effects that trials have not checked
People using research retatrutide told these stories. The claims didn't come from controlled studies, and no trial has checked them. The dose and bottle contents can't be confirmed. One person's story may not fit another person.
Commonly named benefits:
Less hunger and fewer food thoughts. People say food no longer fills their thoughts. Some lose the wish to eat. That isn't the same as feeling full after dinner.
Fast weight loss. Some people saw the scale move in the first weeks. They felt it moved faster than with drugs used before. One person's words can't prove that claim. Watched Phase 2 results carry more weight. The GLP-1 gut hormone may curb hunger. GLP-1 also slows the stomach.
Other named benefits:
Feeling warm. Some people report warmth, flushing, or sweat. They blame the hormone that helps spend stored energy. The body may make more heat during that work. No watched study has shown the cause.
A brighter mood. A few people say food caused less worry. They also found meals less burdensome. In animals, the copied hunger hormone changed some brain activity. Human studies haven't shown the same cause. An animal result can't explain a person's mood.
Commonly named side effects:
Nausea in the first weeks. People often mention nausea after a shot. Some felt worst 4-8 hours later. They report more nausea after raising the amount. Many say it eased with time. In another Phase 2 report, up to 45% had nausea at the top dose.
Other named side effects:
A quicker resting pulse. Some people notice a faster pulse after a shot. Their watches showed rises of 5-15 beats a minute. Phase 2 studies also found a rise. It peaked near 24 weeks [1].
Burps with a sulfur smell. People often mention the bad odor. Food may remain in the stomach longer. People say the burps come and go.
Low energy. Heavy legs and extra sleep appear in some accounts. Others describe a tired, foggy spell after a shot. They blame eating much less.
Constipation. People report fewer bowel movements. Less food may play a part. So may slower movement through the gut.
Less often named side effects:
An itchy shot spot. People report a small red patch. They say it often clears within 24-48 hours. Phase 2 studies found this skin problem in about 8% [1].
Poor sleep. Some people notice poor sleep early. These reports can't show the cause.
Muscle loss along with fat. Some people notice less strength or a softer look. Phase 2 work found loss of both muscle and fat. The larger share came from fat. Older adults can ask their doctor about keeping strength.
Read the stories as stories, not proof.
Retatrutide still has unknown long-term risks
A bottle sold outside a trial may contain something else. Retatrutide studies are still running. Outside a trial, no drug agency checks the label or strength. Tests of similar unapproved products found damaged drug material and other substances. A dirty shot can put germs in the blood. In 2025, the FDA mailed sellers over 50 warning letters [1].
Stomach and bowel trouble drove people from studies. Common troubles were nausea, vomiting, constipation, and diarrhea. Larger doses brought more. At the top dose, 18% left the Phase 2 obesity study. Doctors watched these people. The copied GLP-1 hormone keeps food in the stomach longer [1][2][4]. That helps explain the trouble. Severe vomiting or diarrhea can dry you out. It can also upset the salts in your blood.
The pulse climbed as the dose climbed. At top doses, the average rise was about 5-7 beats a minute. The high point came near 24 weeks [1]. The hormone tied to liver fat can also speed the heart. Doctors saw that rise in Phase 2. They began a larger heart study because of it. The new study hasn't settled uneven beats or lasting harm.
Some diabetes drugs can lower sugar too far. Retatrutide helps the body release insulin. Extra insulin or some pills may lower sugar too far. Doctors lowered insulin for users in the Phase 2 study [2][4]. Without blood tests, a sharp drop can go unseen.
Some muscle was lost. A 2025 Phase 2 study found muscle loss with fat loss. The people had type 2 diabetes [10]. Muscle loss may matter more with age. Protein and strength work can help during weight loss. Your doctor can judge what is safe.
Lasting safety isn't known. Heart and kidney studies were still running in mid-2026. People often regain weight after stopping similar drugs [10][11]. One current study is watching the kidneys. Years of GLP-1 drug use can't settle retatrutide's risks. Doctors still lack long follow-up.
Tell your doctor about every diabetes drug you take.